How to Maximize the Potential of mTOR Inhibitors in Breast Cancer—More ... Cancer Network In this issue of ONCOLOGY, Shaveta Vinayak and Robert Carlson thoroughly summarize the preclinical and clinical studies of mTOR inhibitors, by breast cancer subtype, in both the metastatic and the adjuvant or neoadjuvant setting. Current clinical ... |
